Globus Medical Q1 Earnings Call Highlights

Globus Medical (NYSE:GMED) reported a strong start to 2026, with first-quarter revenue and earnings rising sharply as the company cited continued momentum in U.S. spine, margin expansion and contributions from its Nevro acquisition. President and Chief Executive Officer Keith Pf